Needham & Company Maintains Hold Rating on Omeros (OMER), Reiterates Belief FDA Will Require Additional Trial for narsoplimab Mar 2, 2022 06:24AM
Meedham Remains Sidelined on Omeros (OMER), Will Review Recommendation Once Bill Is Finalized Mar 22, 2018 01:16PM
Needham & Company Downgrades Omeros Corp. (OMER) to Hold Mar 2, 2018 01:09PM
Pre-Open Movers 08/22: (DSW (RT) (JASO) Higher; (TEAR) (CMCM) (NDSN) Lower (more...) Aug 22, 2017 09:22AM
Omeros to Present at the Needham Healthcare Conference Apr 3, 2017 07:00AM


Mar 17, 2017 06:24AM Omeros Corp. (OMER) PT Lowered to $22 at Needham & Company Following 4Q Report; 'OMS721 Ph3 Trial Now Underway'
Nov 10, 2016 07:04AM Needham & Company Remains Bullish on Omeros (OMER) Following Mixed 3Q
Apr 7, 2016 07:00AM Omeros to Present at the 15th Annual Needham Healthcare Conference
Nov 10, 2015 02:18PM Needham & Company Cuts Price Target on Omeros (OMER) Following 3Q
Aug 31, 2015 09:44AM Initial Data from Omeros' (OMER) OMS721 Phase 2 Data Shows Promise - Needham & Company
Apr 9, 2015 04:31PM Omeros to Present at the 14th Annual Needham Healthcare Conference
Mar 17, 2015 03:27PM Omeros (OMER) PT Raised to $32 at Needham & Company Into Spring U.S. Launch of Omidria
Mar 14, 2014 08:35AM Omeros (OMER) Prices 3.04M Common Offering at $11.50/Share
Dec 28, 2012 08:39AM Needham & Company Reiterates Buy on Omeros Corp. (OMER) on Mixed OMS103HP Results
Dec 4, 2012 07:50AM Needham & Company Upgrades Omeros Corp. (OMER) to Buy on Valuation
Jul 18, 2012 01:00PM Needham & Company Maintains a 'Hold' on Omeros Corp. (OMER); Early Stage Pipeline
Jan 10, 2012 01:43PM Unusual 11 Midday Movers 01/10: (OMER) (VOXX) (CRL) (PWRD) Higher; (WBMD) (HMA) (GNOM) (HITK) Lower
Jan 6, 2012 10:31AM Needham & Company Maintains a 'Hold' on Omeros Corp. (OMER); 2012 Preview
Sep 22, 2011 02:41PM Needham & Company Maintains a 'Hold' on Omeros Corp. (OMER); Pipeline is Relatively Early-Stage
May 12, 2011 07:55AM Needham & Company Maintains a 'Hold' on Omeros Corp. (OMER); Q1 Review
Apr 1, 2011 01:59PM Unusual 11 Mid-Day Movers 04/01: (HRZ) (INHX) (IRE) Higher; (OMER) (EXFO) (ASTI) Lower
Apr 1, 2011 11:05AM Morning Movers 04/01: (HRZ) (IRE) (ALEX) Higher; (OMER) (EXFO) (CDTI) Lower
Apr 1, 2011 08:17AM Needham & Company Downgrades Omeros Corp. (OMER) to Hold; 3 Trials of OMS103HP in ACL Surgery Miss Primary Endpoint in Knee Function
Jan 6, 2011 08:39AM Needham & Company Reiterates a 'Buy' on Omeros Corp. (OMER); 2011 Preview
Oct 26, 2010 09:13AM Needham & Company Reiterates a 'Buy' on Omeros Corp. (OMER); New Funding to Support GPCR Program, Although Concerns on Development Timelines
May 13, 2010 08:08AM Needham & Company Reiterates a 'Buy' on Omeros Corp. (OMER); 1Q10 Review
Apr 1, 2010 08:33AM Needham & Company Reit Buy Rating On Omeros (OMER)
Dec 1, 2009 07:45AM Needham & Co Initiates Coverage on Omeros (OMER) with a Buy
Oct 8, 2009 12:00PM Omeros (OMER) IPO Trades Lower
Oct 8, 2009 09:26AM Omeros (OMER) Prices IPO at $10, Low End of Range
Sep 17, 2009 12:18PM Omeros (OMER) Sees IPO Price of $10-$12